ELSE Nutrition Toddler Products to Launch in Over 380 U.S. Retail Locations in November 2020

ELSE rapidly expands distribution to provide nationwide product availability in retail, Amazon.com and Else’s e-store

VANCOUVER, BC, Oct. 28, 2020 /CNW/ – ELSE NUTRITION HOLDINGS INC. (TSXV: BABY) (OTCQX: BABYF) (FSE: 0YL) (“Else” or the “Company“), a commercial stage developer of plant-based alternatives to dairy-based baby nutrition, is pleased to  provide an update on upcoming availability of the Company’s products in U.S. retail stores.

The Company expects to begin its initial store distribution via KeHE Distributors in western and southern regions of the United States as early as late November 2020, and is to include up four regional accounts and one national key account, totaling 380 stores in advance of the Christmas season.

U.S. Retail Distribution and Rollout

Following the recent successful e-store and Amazon launch for its plant-based toddler nutrition line, Else has been working diligently through its network of retail brokers and KeHE Distributors on strategic ‘Brick & Mortar’ account listings across various critical US regions.

“We are very encouraged with the aggressive interest we have received for our product. Parents and families have waited a long time for a plant-based alternative to dairy-based baby nutrition.  Soon parents across the United States will be able to find our product at stores near them in addition to being able to order online,” said Mrs. Hamutal Yitzhak, CEO and Co-Founder of Else.

About Else Nutrition Holdings Inc.

Else Nutrition GH Ltd. is an Israel-based food and nutrition company focused on developing innovative, clean and plant-based food and nutrition products for infants, toddlers, children, and adults. Its revolutionary, plant-based, non-soy, formula is a clean-ingredient alternative to dairy-based formula. Else Nutrition (formerly INDI) won the “2017 Best Health and Diet Solutions” award at the Global Food Innovation Summit in Milan. The holding company, Else Nutrition Holdings Inc., is a publicly traded company, listed as TSX Venture Exchange under the trading symbol BABY and is quoted on the US OTC Markets QX board under the trading symbol BABYF and on the Frankfurt Exchange under the symbol 0YL. Else’s Executives includes leaders hailing from leading infant nutrition companies. Many of Else advisory board  members had past executive roles in companies such as Mead Johnson, Abbott Nutrition, Plum Organics and leading infant nutrition Societies,  and some of them currently serve in different roles in leading medical centers and academic institutes such as Boston Children’s Hospital, Pediatrics at Harvard Medical School, USA, Tel Aviv University, Schneider Children’s Medical Center of Israel, Rambam Medical Center and Technion, Israel and University Hospital Brussels, Belgium.

For more information, visit: elsenutrition.com or @elsenutrition on Facebook and Instagram.

TSX Venture Exchange

Neither the TSX Venture Exchange nor its regulation services provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Caution Regarding Forward-Looking Statements

This press release contains statements that may constitute “forward-looking statements” within the meaning of applicable securities legislation. Forward-looking statements are typically identified by words such as “will” or similar expressions. Forward-looking statements in this press release include statements with respect to the anticipated dates for filing the Company’s financial disclosure documents.  Such forward-looking statements reflect current estimates, beliefs and assumptions, which are based on management’s perception of current conditions and expected future developments, as well as other factors management believes are appropriate in the circumstances. No assurance can be given that the foregoing will prove to be correct. Forward-looking statements made in this press release assume, among others, the expectation that there will be no interruptions or supply chain failures as a result of COVID 19 and that the manufacturing, broker and supply logistic agreement with the Company do not terminate.  Actual results may differ from the estimates, beliefs and assumptions expressed or implied in the forward-looking statements.  Readers are cautioned not to place undue reliance on any forward-looking statements, which reflect management’s expectations only as of the date of this press release. The Company disclaims any obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.

SOURCE Else Nutrition Holdings Inc.

For further information: Ms. Hamutal Yitzhak, CEO, Co-Founder & Director, ELSE Nutrition Holdings Inc., E: [email protected], P: +972(0)3-6445095; Mr. Sokhie Puar, Director of Else Nutrition, Email: [email protected], Telephone: 604-603-7787